Cancer Institute A national cancer institute
designated cancer center

Ann M. Arvin

Publication Details

  • Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.

    Ngai AL, Staehle BO, Kuter BJ, Cyanovich NM, Cho I, Matthews H, Keller P, Arvin AM, Watson B, White CJ. Pediatr Infect Dis J. 1996; 15 (1): 49-54

    To compare the safety and immunogenicity of a one- vs. two-dose regimen of Oka/Merck varicella vaccine in approximately 2000 healthy children 12 months to 12 years of age.

    PubMedID: 8684876

Stanford Medicine Resources:

Footer Links: